Abstract:Background:The ongoing global coronavirus disease 2019 (COVID-19) pandemic is posing a serious public health threat to nations worldwide. Understanding the pathogenesis of the disease and host immune responses will facilitate the discovery of therapeutic targets and better management of infected patients. Metabolomics technology can provide an unbiased tool to explore metabolic perturbation.Methods:Twenty-six healthy controls and 50 COVID-19 patients with mild, moderate, and severe symptoms in the Fifth Medical Center of PLA General Hospital from January 22 to February 16, 2020 were recruited into the study. Fasting blood samples were collected and subject to metabolomics analysis by liquid chromatography-mass spectrometry. Metabolite abundance was measured by peak area and was log-transformed before statistical analysis. The principal component analysis, different expression analysis, and metabolic pathway analysis were performed using R package. Co-regulated metabolites and their associations with clinical indices were identified by the weighted correlation network analysis and Spearman correlation coefficients. The potential metabolite biomarkers were analyzed using a random forest model.Results:We uncovered over 100 metabolites that were associated with COVID-19 disease and many of them correlated with disease severity. Sets of highly correlated metabolites were identified and their correlations with clinical indices were presented. Further analyses linked the differential metabolites with biochemical reactions, metabolic pathways, and biomedical MeSH terms, offering contextual insights into disease pathogenesis and host responses. Finally, a panel of metabolites was discovered to be able to discriminate COVID-19 patients from healthy controls, and also another list for mild against more severe cases. Our findings showed that in COVID-19 patients, citrate cycle, sphingosine 1-phosphate in sphingolipid metabolism, and steroid hormone biosynthesis were downregulated, while purine metabolism and tryptophan metabolism were disturbed.Conclusion:This study discovered key metabolites as well as their related biological and medical concepts pertaining to COVID-19 pathogenesis and host immune response, which will facilitate the selection of potential biomarkers for prognosis and discovery of therapeutic targets.

Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis

Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19

Metabolomic analyses reveal new stage-specific features of COVID-19

Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage

A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19

The Serum Metabolome of COVID-19 Patients is Distinctive and Predictive

The trans-omics landscape of COVID-19

Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19

Metabolomic alterations in the plasma of patients with various clinical manifestations of COVID-19

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Association of Altered Plasma Lipidome with Disease Severity in COVID-19 Patients

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Metabolite profile of COVID-19 revealed by UPLC-MS/MS-based widely targeted metabolomics

Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge

Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage

Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19

Multiomics integration-based molecular characterizations of COVID-19

Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Integrated multiomics analysis to infer COVID-19 biological insights

Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients